Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Johnson and Johnson
Harvard Business School
Cantor Fitzgerald
Chinese Patent Office
Healthtrust
Deloitte
Baxter
Daiichi Sankyo

Generated: June 18, 2018

DrugPatentWatch Database Preview

DALVANCE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Dalvance, and when can generic versions of Dalvance launch?

Dalvance is a drug marketed by Allergan Sales Llc and is included in one NDA. There are four patents protecting this drug.

This drug has fifty-three patent family members in sixteen countries.

The generic ingredient in DALVANCE is dalbavancin hydrochloride. One supplier is listed for this compound. Additional details are available on the dalbavancin hydrochloride profile page.
Summary for DALVANCE
International Patents:53
US Patents:4
Applicants:1
NDAs:1
Suppliers / Packagers: 1
Bulk Api Vendors: 5
Clinical Trials: 2
Patent Applications: 1
DailyMed Link:DALVANCE at DailyMed
Drug patent expirations by year for DALVANCE
Pharmacology for DALVANCE
Synonyms for DALVANCE
247175-55-9
808UI9MS5K
A-A-1
B0U42518WL
BI 397
BI-397
BI397
CHEBI:82721
CHEMBL3301669
CS-3579
Dalbavancin
Dalbavancin [USAN:INN:BAN]
dalbavancin B0
Dalbavancin Hydrochloride
HY-17586
KGPGQDLTDHGEGT-SZUNQUCBSA-N
MDL 63,397
MDL 64,397
MDL-64397
UNII-808UI9MS5K
UNII-808UI9MS5K component KGPGQDLTDHGEGT-SZUNQUCBSA-N
UNII-B0U42518WL
VER 001
VER001
VERO001
Xydalba

US Patents and Regulatory Information for DALVANCE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan Sales Llc DALVANCE dalbavancin hydrochloride POWDER;IV (INFUSION) 021883-001 May 23, 2014 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Allergan Sales Llc DALVANCE dalbavancin hydrochloride POWDER;IV (INFUSION) 021883-001 May 23, 2014 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Allergan Sales Llc DALVANCE dalbavancin hydrochloride POWDER;IV (INFUSION) 021883-001 May 23, 2014 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Allergan Sales Llc DALVANCE dalbavancin hydrochloride POWDER;IV (INFUSION) 021883-001 May 23, 2014 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Boehringer Ingelheim
Moodys
US Army
Argus Health
Cerilliant
Citi
Johnson and Johnson
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.